Literature DB >> 30643566

Synchronous primary adenocarcinoma of the lung and pancreas: a case series and review of the literature.

Akshjot Puri1,1, Ly Ma2,2, Gary V Walker2,2, John Chang2,2, Ron Z Shinar1,1, Madappa N Kundranda2,2.   

Abstract

AIM: The frequency of pancreatic cancer in association with cancer of other organs ranges from 1 to 20%, with the most common ones being gastric, colon, thyroid and genitourinary. The presence of synchronous lung and pancreatic cancers is extremely rare. CASE SERIES: Two patients with extensive smoking history and variable presentations were found to have simultaneous lung and pancreatic masses both lesions being different histologically and on immunohistochemical staining. After individualized treatment plans, the first patient remains free of disease and the second patient is being treated with a palliative intent.
CONCLUSION: The early recognition and treatment is important as there exists a significant survival difference in patients who have synchronous primaries as opposed to those with metastatic pancreatic adenocarcinoma.

Entities:  

Keywords:  lung adenocarcinoma; pancreatic adenocarcinoma; synchronous primaries

Year:  2017        PMID: 30643566      PMCID: PMC6310336          DOI: 10.2217/lmt-2017-0003

Source DB:  PubMed          Journal:  Lung Cancer Manag        ISSN: 1758-1966


  13 in total

1.  A case of synchronous pancreatic ductal adenocarcinoma and ovarian mucinous cystic neoplasm: use of kras mutation molecular phenotyping to demonstrate independent primary origin.

Authors:  Maeve Lowery; David Klimstra; Cyrus Hedvat; William Jarnagin; Dennis Chi; Eileen M O'Reilly
Journal:  Gastrointest Cancer Res       Date:  2012-03

2.  Pancreatic resection for pancreatic cancer.

Authors:  Jeannine Bachmann; Christoph W Michalski; Marc E Martignoni; Markus W Büchler; Helmut Friess
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

3.  Pulmonary resection for isolated pancreatic adenocarcinoma metastasis: an analysis of outcomes and survival.

Authors:  George J Arnaoutakis; Deepa Rangachari; Daniel A Laheru; Chris A Iacobuzio-Donahue; Ralph H Hruban; Joseph M Herman; Barish H Edil; Timothy M Pawlik; Richard D Schulick; John L Cameron; Avedis Meneshian; Stephen C Yang; Christopher L Wolfgang
Journal:  J Gastrointest Surg       Date:  2011-07-02       Impact factor: 3.452

4.  Multiple primaries in pancreatic cancer patients: indicator of a genetic predisposition?

Authors:  B Gerdes; A Ziegler; A Ramaswamy; A Wild; P Langer; D K Bartsch
Journal:  Int J Epidemiol       Date:  2000-12       Impact factor: 7.196

5.  KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.

Authors:  Alyssa M Krasinskas; Simon I Chiosea; Timothy Pal; Sanja Dacic
Journal:  Mod Pathol       Date:  2013-07-26       Impact factor: 7.842

6.  Synchronous or metachronous double cancers of the pancreas and other organs: report on 12 cases.

Authors:  N Eriguchi; S Aoyagi; M Hara; K Okuda; T Tamae; S Fukuda; K Hashino; S Sato; K Fujiki; S Furukawa; A Jimi
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

7.  [Multiple primary cancers in surgically resected lung cancer patients].

Authors:  H Nishiyama; H Kaguraoka; M Kuroki; K Takahashi; T Kitaya; T Matsuyama
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1989-01

8.  DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Authors:  Christine A Iacobuzio-Donahue; Baojin Fu; Shinichi Yachida; Mingde Luo; Hisashi Abe; Clark M Henderson; Felip Vilardell; Zheng Wang; Jesse W Keller; Priya Banerjee; Joseph M Herman; John L Cameron; Charles J Yeo; Marc K Halushka; James R Eshleman; Marian Raben; Alison P Klein; Ralph H Hruban; Manuel Hidalgo; Daniel Laheru
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

9.  Pancreatic tumors in patients with lung malignancies: a spectrum of clinicopathologic considerations.

Authors:  Roderich E Schwarz; Peiguo G Chu; Frederic W Grannis
Journal:  South Med J       Date:  2004-09       Impact factor: 0.954

Review 10.  The pathology and genetics of metastatic pancreatic cancer.

Authors:  Shinichi Yachida; Christine A Iacobuzio-Donahue
Journal:  Arch Pathol Lab Med       Date:  2009-03       Impact factor: 5.534

View more
  1 in total

1.  Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab.

Authors:  David L Saltman; Tyler J Nielsen; Davide Salina; David R Hout; Frank B McMahon; Boris R Valev; Michael Huk; Pranil K Chandra; Jeremy Spille; Robert S Seitz; Brock L Schweitzer
Journal:  Ther Adv Med Oncol       Date:  2021-04-19       Impact factor: 8.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.